Global Medical REIT Reports Q2 FFO of $0.20, Revenue of $37.97M

Global Medical REIT reported Q2 FFO of $0.20 in-line and revenue of $37.97M, beating the estimate by $2.4M. The company appointed Mark Decker, Jr. as CEO and completed the acquisition of a $69.6 million five-property medical portfolio.

Global Medical REIT Inc. (NYSE: GMRE) reported its second-quarter (Q2) 2025 financial results, which included funds from operations (FFO) of $0.20 per share, in line with estimates, and revenue of $37.97 million, beating the estimate by $2.4 million. The company also appointed Mark Decker, Jr. as its new Chief Executive Officer (CEO) and completed the acquisition of a $69.6 million five-property medical portfolio.

The FFO of $0.20 per share was in line with analyst expectations, while the revenue of $37.97 million exceeded the estimate by $2.4 million, indicating strong performance during the quarter. The company's adjusted funds from operations (AFFO) of $0.23 per share and unit was also in line with expectations.

Mark Decker, Jr. was appointed as the new CEO, replacing the outgoing CEO. Decker brings extensive experience in the healthcare and real estate sectors, which is expected to drive strategic growth for the company. Decker stated, "I’m excited to be on board as we report our first quarter as a new team here at Global Medical. We have an outstanding niche and I look forward to honing that further and driving results for all our stakeholders in the coming years."

In addition to the appointment of a new CEO, the company completed the acquisition of a $69.6 million five-property medical portfolio. The acquisition, which encompassed an aggregate of 297,724 leasable square feet, was completed in April 2025. The aggregate annualized base rent of the acquired properties is $3.6 million.

Global Medical REIT also sold a medical facility in Chipley, Florida, in May 2025, receiving gross proceeds of $1.4 million and realizing a gain of $0.2 million. The company reported a net loss of $0.8 million for the quarter, compared to $3.1 million in the same period last year.

The company reaffirmed its full-year 2025 AFFO guidance of $0.89 to $0.93 per share and unit, based on certain assumptions and factors, including no additional acquisitions or dispositions other than activity that has been either completed or announced, and no additional equity or debt issuances other than normal course Revolver borrowing/repayments.

The company's stock price has seen fluctuations, with a recent increase of 6.4% in the last session, but it remains to be seen if this trend will continue.

References
[1] https://seekingalpha.com/news/4479106-global-medical-reit-ffo-of-0_20-in-line-revenue-of-37_97m-beats-by-2_4m
[2] https://ca.finance.yahoo.com/quote/GMRE/news/
[3] https://finance.yahoo.com/news/global-medical-reit-announces-second-200700805.html